MondayOct 19, 2020 9:59 am

QualityStocksNewsBreaks – PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) Expanding Platform to Offer DRIVRZ Credit Cards

PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA), a fintech provider disrupting the automotive industry, today announced that it will offer U.S. consumers and automotive dealerships DRIVRZ-branded credit cards through an agreement with DigniFi, a leading U.S.-based auto-financing company. According to the update, the credit cards will be offered through PowerBand's virtual transaction platform - now being trademarked under the DRIVRZ brand. Under the agreement, approvals for DRIVRZ credit cards will be managed by DigniFi, which has a national presence in more than 5,000 U.S. automotive retail and repair centers. "The DRIVRZ credit card will be available to consumers on…

Continue Reading

FridayOct 16, 2020 1:43 pm

QualityStocksNewsBreaks – Net Element Inc.’s (NASDAQ: NETE) Foray into EV Market Driven by Dragonfly K50

Net Element (NASDAQ: NETE) has recently transformed its business model to become a pure-play electric vehicle (“EV”) manufacturer through its merger with privately-held Mullen Technologies Inc. The company is set to begin marketing its initial vehicle model – the Dragonfly K50 – in 2Q2021. Developed in conjunction with China’s Qiantu Motors, the car model will mark Net Element’s initial foray into the North American electric vehicle market. The venture will be further reinforced through the launch of the Mullen MX-5, the company’s self-manufactured EV SUV, by the second quarter of 2022. An article discussing opportune timing of the move reads,…

Continue Reading

FridayOct 16, 2020 1:24 pm

QualityStocksNewsBreaks – Sharing Services Global Corporation (SHRG) Among Fastest-Growing Small-Cap Companies in Direct-Selling Renaissance

Sharing Services Global (OTCQB: SHRG), a diversified holding company specializing in the health and wellness direct-selling industry, was featured in a recent Transformation Capital industry report (https://ibn.fm/NnFte). In the report, the investment banking and business development firm highlights SHRG as one of the fastest-growing small-cap companies in the direct-selling space, noting its top performance among all stocks in the index’s tracking set. An article discussing this outlines Transformation Capital’s projections for the industry to continue to perform, leveraging the momentum built since the beginning of 2020 to drive the sector to a new potential record-breaking year. “From a broad perspective, we…

Continue Reading

FridayOct 16, 2020 10:57 am

180 Life Sciences Corp. Expands IP Portfolio with EU, U.S., and Chinese Patents

The company’s patent portfolio includes its own intellectual property and exclusive worldwide licenses, including in the U.S., Canada, Europe, Australia, Hong Kong, and China 180 Life Sciences is in the final stages of its merger process with KBL Merger Corp. IV, with the resulting entity to list on NASDAQ under the ticker “ATNF” The company is devoting its clinical-stage biotechnology research to producing solutions that will help battle inflammation. Its primary focus is to treat fibrosis and inflammation using anti-TNF therapy The estimated annual market size for anti-inflammatory therapeutics is projected to grow to an estimated $106.1 billion in 2020.…

Continue Reading

FridayOct 16, 2020 10:19 am

Rritual Mushrooms Inc. Takes Aim at New Wellness Industry in Functional Foods Marketplace

Rritual Mushrooms Inc. is an emerging producer of premium plant-based superfood products designed to help people meet the demands of modern life with style and ease The company introduced the wellness and nutraceuticals market to its suite of three mushroom and adaptogen-based elixir powders in September Rritual Mushrooms’ products were created to boost immunity, support brain function and help the body fight anxiety Rritual is positioned to take advantage of lifestyle trends that have promoted plant-based proteins and reduced meat consumption in recent years, as well as an invigorated interest in immunity-enhancing substances brought on by the worldwide COVID-19 pandemic…

Continue Reading

ThursdayOct 15, 2020 2:49 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc.’s (PBIO) Path to Commercialization Targets Multibillion Hemp-Derived CBD Market

Pressure BioSciences (OTCQB: PBIO), a developer of innovative solutions for the worldwide life science and other industries, recently achieved another milestone as it nears initial production of commercial systems expected to revolutionize the nanoemulsification process for a wide variety of sectors. The company’s proprietary, next-generation Ultra Shear Technology-based BaroShear K45 System is designed to create unique, high-quality nanoemulsions of otherwise poorly soluble oils in order to render them more easily absorbed and effective in the water-based biology of human bodies. Pressure BioSciences earlier this year announced the launch of its UST Demonstration Laboratory as a place to showcase the technology’s…

Continue Reading

ThursdayOct 15, 2020 2:15 pm

QualityStocksNewsBreaks – GoldHaven Resources Corp. (CSE: GOH) (OTCQB: ATUMF) Ramps Up for 2021 Drill Program Amid Gold’s Upward Climb

GoldHaven Resources (CSE: GOH) (OTCQB: ATUMF), a Canada-based company engaged in the business of acquiring and exploring mineral resource properties, stands to benefit from the upward trajectory of the gold market. The trend is featured in a recent CNBC article, titled “Citi Economists Explain Why Gold Surged Above $2,000, and What It Could Tell Us.” The piece highlights a nine-week track of consecutive gains in the spot gold price with Citi experts indicating their projections for the metal to reach $2,100 an ounce this quarter, and $2,300 in the next 6 to 12 months, with “risks skewed to the upside.”…

Continue Reading

ThursdayOct 15, 2020 1:57 pm

QualityStocksNewsBreaks – Predictive Oncology Inc.’s (NASDAQ: POAI) Soluble Biotech Looks to Bright Future with First Contract on the Books

Predictive Oncology (NASDAQ: POAI)’s Soluble Biotech division has finalized its first substantial contract with a pharmaceutical company since its acquisition by POAI earlier this year (https://ibn.fm/gXjd2). Soluble Biotech is a provider of stable and soluble formulations for proteins including vaccines, antibodies, large and small proteins and protein complexes. Under the contract, Soluble Biotech will provide its expertise in protein expression and solubility studies. A recent article discussing this quotes Soluble Biotech founder Dr. Larry DeLucas. “Our first contract is a major milestone and validates our recent move into a new, larger facility,” Dr. DeLucas stated. “We quadrupled our laboratory and…

Continue Reading

ThursdayOct 15, 2020 1:13 pm

Net Element Inc. (NASDAQ: NETE) Well-Poised to Capitalize as EV Market Set to Grow by 29% per Annum Over Next Decade

Net Element’s reverse merger with EV manufacturer Mullen Technologies expected to close by 4Q2020 Mullen expects to begin marketing Dragonfly K50, sold in conjunction with JV partner Qiantu Motors from 2Q2021 followed by its own EV SUV in 2022 Deloitte expects annual EV sales to rise from 2.5mn in 2020 to 31.1mn in 2030, implying 29% CAGR over next ten years By 2030, EVs expected to account for 32% of all automobile sales globally, approximately 27% in United States Net Element (NASDAQ: NETE), a financial technology company which has recently transformed its business model to become a pure-play electric vehicle…

Continue Reading

ThursdayOct 15, 2020 12:23 pm

AzurRx BioPharma Inc. (NASDAQ: AZRX) is “One to Watch”

AzurRx BioPharma’s lead therapeutic, MS1819, is a recombinant lipase treatment for exocrine pancreatic insufficiency and is currently targeting patients with cystic fibrosis and chronic pancreatitis – an established global market of more than $2 billion The company is currently pursuing parallel monotherapy and combination therapy trials, which are anticipated to produce topline data in Q1 2021 and Q2 2021, respectively Previously completed clinical trials of MS1819 showed primary and secondary endpoint efficacy, with a positive safety profile To fully finance its ongoing Phase 2 trials and being preparations for a pivotal Phase 3 study in 2021, as well as to…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered